CSL shares are down nearly 20% over 5 years. Is the stock undervalued today? Let's see what JP Morgan and other experts think ...

It can also be expected that decisions on recommendations for booster vaccinations will be made, even in the absence of serological markers for protection. By the end of the century, many patents ...

Expert Rev Vaccines. 2010;9(5):497-502. Thus, parents and caregivers should be reassured based on these data that vaccines will not overwhelm or weaken the infant immune system. The schedule of ...

Fluad is an influenza vaccine that includes an adjuvant to enhance immunity and was approved by the Ministry of Food and Drug Safety for use in individuals aged 65 and older in September 2022.